Moderna Just Gave Investors Yet Another Thing to Cheer About
Moderna's cancer vaccine has been the big story this year, but its latest quarter showed the rest of its business is improving, too.
Moderna's cancer vaccine has been the big story this year, but its latest quarter showed the rest of its business is improving, too.